HSV serological testing - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PROVIDERS & PRESCRIBERS
Main healthcare providers: Pharmacist biologists	52.76%
Main prescribers: General practitioners	31.15%
RATE OF USE
Average number of interventions (per year)	40,058
Standardised rate of use (per 100,000 insured persons)	345.91
≥ 2 occurences per patient 2021	55.99%
Percentage of outpatient care	81.14%
POPULATION
Median age	40 years
Max/min ratio of the median age (by district)	1.47
Percentage of women	56.73%
Ratio Preferential scheme/General scheme	1.24
TRENDS
Trend 2012-2022	2.60%
Trend 2012-2019	3.74%
Trend 2019-2022	-0.01%
GEOGRAPHICAL VARIATIONS
Coefficient of variation 2012-2014	71.12
Coefficient of variation 2020-2022	63.81
Max/min ratio of number of interventions (per 100,000 insured persons, by region)	3.47
Max/min ratio of number of interventions (per 100,000 insured persons, by district)	11.66
DIRECT EXPENDITURE
Average annual expenditure	89,139 €
Average annual expenditure per insured person	0.01 €
Max/min ratio of expenditure per insured person (by region)	3.49
Max/min ratio of expenditure per insured person(by district)	11.72
Average cost of interventions	2.23 €

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - NIHDI nomenclature codes selected for analysis Click to collapse

CODES	LABEL	CREATION	DELETION
551935 551946	Recherche d'anticorps IgG contre le virus de l'herpès simplex #(Maximum 1)(Règle de cumul 328)(Règle diagnostique 52)	01-04-1997
551950 551961	Recherche d'anticorps IgM contre le virus de l'herpès simplex #(Maximum 1)(Règle de cumul 328)(Règle diagnostique 81)	01-04-1997